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Background
Cellular levels of cyclic GMP (cGMP) are tightly controlled
by synthetic and degradative mechanisms. Pharmacological
manipulation of these processes (e.g. soluble guanylate
cyclase stimulators, phosphodiesterase 5 inhibitors) aug-
ments cGMP-dependent signalling and is beneficial in
treating cardiovascular disease (e.g. pulmonary hyperten-
sion). An additional mechanism potentially important in
regulating cGMP signalling is cellular extrusion, driven by
a family of multidrug resistance proteins (MRPs). Herein,
we investigated if inhibition of MRPs modulates vascular
reactivity, smooth muscle cell proliferation, and systemic
hemodynamics.
Methods and main findings
The functional reactivity of murine aortic rings and prolif-
eration of human pulmonary artery smooth muscle cells
(PASMC) were determined in the absence and presence of
the MRP inhibitor MK571. Hemodynamic changes in vivo
in response to MK571 were analysed acutely by bolus
dosing and chronically by radiotelemetry.
MK571 (1nM-50µM) caused a concentration-dependent
relaxation of mouse aortic rings. In the presence of a
threshold concentration of MK571 (3µM), vasorelaxant
responses to NO and atrial natriuretic peptide (ANP) were
significantly augmented. MK571 (3µM) also significantly
inhibited PASMC proliferation and enhanced the anti-
mitogenic properties of ANP (1µM) and NO. In vivo,
MK571 (0.001-10mg/kg; i.v.) elicited an acute, dose-
dependent hypotensive activity and when delivered via the
drinking water caused a more sustained drop in mean
arterial pressure (~5 mmHg).
Conclusion
These data suggest that extrusion by MRPs contributes
to the dynamic equilibrium regulating intracellular levels
of cGMP, and may represent a further target amenable
to drug intervention for the treatment of cardiovascular
disease.
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